The National Science Advisory Board for Biosecurity will perform the review, which NIH says is unrelated to the ongoing debate over the pandemic’s origins. One theory is that the virus accidentally leaked from a laboratory in China, though a mounting body of evidence suggests the virus likely originated from live animals sold at a market in Wuhan.
Based on the review, the advisory committee will develop recommendations for NIH on which experiments will require special safety measures and which are too dangerous to perform.
“This is an appropriate time for us to undertake and ensure that our policies are allowing potential benefits of research while managing potential risks,” Lyric Jorgenson, PhD, acting associate director for science policy at NIH, told the Post. “This is around definitions of what should be in and what should be out.”
NIH said it hopes to have the new recommendations by the end of 2022.
View the full article here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
